English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 909235      Online Users : 782
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    會議論文/會議摘要 [30/48]
    專利 [0/42]

    Collection Statistics

    近3年內發表的文件:12(8.51%)
    含全文筆數:141(100.00%)

    文件下載次數統計
    下載大於0次:141(100.00%)
    下載大於100次:138(97.87%)
    檔案下載總次數:84081(82.42%)

    最後更新時間: 2024-12-01 12:03


    上傳排行

    資料載入中.....

    下載排行

    資料載入中.....

    RSS Feed RSS Feed
    跳至:
    或輸入年份:
    由新到舊排序 由最舊的開始

    顯示項目26-50 / 141. (共6頁)
    << < 1 2 3 4 5 6 > >>
    每頁顯示[10|25|50]項目

    日期題名關聯
    2020-03-01 A selective Aurora-A 5'-UTR siRNA inhibits tumor growth and metastasis Cancer Letters. 2020 Mar 1;472:97-107.
    2020-01 Identification of novel quinoline inhibitor for EHMT2/G9a through virtual screening Biochimie. 2020 Jan;168:220-230.
    2019-12 Lysosomal cysteine protease cathepsin S is involved in cancer cell motility by regulating store-operated Ca(2+) entry Biochimica et Biophysica Acta. Molecular Cell Research. 2019 Dec;1866(12):Article number 118517.
    2019-11-27 Discovery of a furanopyrimidine-based epidermal growth factor receptor inhibitor (DBPR112) as a clinical candidate for the treatment of non-small cell lung cancer Journal of Medicinal Chemistry. 2019 Nov 27;62(22):10108-10123.
    2019-10-08 Identification of two novel small compounds that inhibit liver cancer formation in zebrafish and analysis of their conjugation to nanodiamonds to further reduce toxicity Advanced Therapeutics. 2019 Oct 8;2(12):Article number 1900105.
    2019-07-03 Delineating the active site architecture of G9a lysine methyltransferase through substrate and inhibitor binding mode analysis: A molecular dynamics study Journal of Biomolecular Structure and Dynamics. 2019 Jul 3;37(10):2581-2592.
    2019-07 Dual Kit/Aur inhibitors as chemosensitizing agents for the treatment of melanoma: Design, synthesis, docking studies and functional investigation Scientific Reports. 2019 Jul;9:Article number 9943.
    2019-05-29 Insights for the design of protein lysine methyltransferase G9a inhibitors Future Medicinal Chemistry. 2019 May 29;11(9):993-1014.
    2018-11 Biomimetic Syntheses of (±)‐Isopalhinine A, (±)‐Palhinine A, and (±)‐Palhinine D Angewandte Chemie. 2018 Nov;57(47):15572-15576.
    2018-05-10 Design and synthesis of BPR1K653 derivatives targeting the back pocket of Aurora kinases for selective isoform inhibition European Journal of Medicinal Chemistry. 2018 May 10;151:533-545.
    2018-04-25 Challenging clinically unresponsive medullary thyroid cancer: Discovery and pharmacological activity of novel RET inhibitors European Journal of Medicinal Chemistry. 2018 Apr 25;150:491-505.
    2017-08-11 Targeting P-glycoprotein: Investigation of piperine analogs for overcoming drug resistance in cancer Scientific Reports. 2017 Aug 11;7:Article number 7972.
    2017-07 Drug repurposing for chronic myeloid leukemia: In silico and in vitro investigation of DrugBank database for allosteric Bcr-Abl inhibitors Journal of Biomolecular Structure and Dynamics. 2017 Jun;35(8):1833-1848.
    2016-12 Discovery of BPR1K871, a quinazoline based, multi-kinase inhibitor for the treatment of AML and solid tumors: Rational design, synthesis, in vitro and in vivo evaluation Oncotarget. 2016 Dec;7(52):86239-86256.
    2016-11-29 Discovery of novel inhibitors of Aurora kinases with indazole scaffold: In silico fragment-based and knowledge-based drug design European Journal of Medicinal Chemistry. 2016 Nov 29;124:186-199.
    2016-07 Therapeutic polymeric nanoparticles and the methods of making and using thereof: A patent evaluation of WO2015036792 Expert Opinion on Therapeutic Patents. 2016 Jul;26(7):751-755.
    2016-03 Disruption of protein-protein interactions: Hot spot detection, structure-based virtual screening and in vitro testing for the anti-cancer drug target survivin RSC Advances. 2016 Mar;6(38):31947-31959.
    2015-06-29 Homology modeling of DFG-in FMS-like tyrosine kinase 3 (FLT3) and structure-based virtual screening for inhibitor identification Scientific Reports. 2015 Jun 29;5:Article number 11702.
    2015-02 Function-oriented development of CXCR4 antagonists as selective human immunodeficiency virus (HIV)-1 entry inhibitors Journal of Medicinal Chemistry. 2015 Feb;58(3):1452-1465.
    2015-01 Identification of ligand efficient, fragment-like hits from an HTS library: Structure-based virtual screening and docking investigations of 2H- and 3H-pyrazolo tautomers for Aurora kinase A selectivity Journal of Computer-Aided Molecular Design. 2015 Jan;29(1):89-100.
    2014-12 BPR-3P0128 inhibits RNA-dependent RNA polymerase elongation and VPg uridylylation activities of Enterovirus 71 Antiviral Research. 2014 Dec;112:18-25.
    2014-10 Small-molecule EGFR tyrosine kinase inhibitors for the treatment of cancer Expert Opinion on Investigational Drugs. 2014 Oct;23(10):1333-1348.
    2014-08 CDKN1A-mediated responsiveness of MLL-AF4-positive acute lymphoblastic leukemia to Aurora kinase-A inhibitors International Journal of Cancer. 2014 Aug;135(3):751-762.
    2014-08 Ligand efficiency based approach for efficient virtual screening of compound libraries European Journal of Medicinal Chemistry. 2014 Aug;83:226-235.
    2014-07 Anaplastic lymphoma kinase (ALK) inhibitors: A review of design and discovery MedChemComm. 2014 Jul;5(9):1266-1279.

    顯示項目26-50 / 141. (共6頁)
    << < 1 2 3 4 5 6 > >>
    每頁顯示[10|25|50]項目

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋